The idea of harnessing the body’s response to heal and defend is no longer the stuff of science fiction.
With May 26, 2020 quickly approaching, every day counts.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Manufacturing microfluidic devices requires sophisticated techniques.
The goal of the voluntary program is to streamline the submission process. The agency also announced that it has selected participants for its EtO Innovation Challenges.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.
Treatment can no longer be one dimensional.
Stakeholders warn that more EtO facility closures could have a catastrophic result.
Drop the checkbox mentality and embrace accountability and understanding.
Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.